Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration

NCT00541333 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Reviewing data

Conditions

Dry Age Related Macular Degeneration

Interventions

DRUG: Copaxone Injection

Sponsor

The New York Eye & Ear Infirmary